BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9339257)

  • 1. [Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?].
    Brembilla-Perrot B; Terrier de la Chaise A; Jacquemin L; Beurrier D; Houplon P; Louis P; Danchin N
    Arch Mal Coeur Vaiss; 1997 Jul; 90(7):961-6. PubMed ID: 9339257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Can the supraventricular proarrhythmic effects of class 1C antiarrhythmic drugs be prevented with the association of beta blockers?].
    Brembilla-Perrot B; Houriez P; Claudon O; Yassine M; Suty-Selton C; Vancon AC; Abo el Makarem Y; Makarem E; Courtelour JM
    Ann Cardiol Angeiol (Paris); 2000 Dec; 49(8):439-42; discussion 442-3. PubMed ID: 12555430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atrial flutter with 1:1 AV conduction during intravenous flecainide treatment].
    Heldal M; Orning OM
    Tidsskr Nor Laegeforen; 1989 Aug; 109(23):2309-10. PubMed ID: 2505404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
    Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
    J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Persistent atrial flutter induced by propafenone (Rytmonorm)].
    Fazekas T; Kiss J; Pap I; Rudas L
    Orv Hetil; 1994 Aug; 135(33):1819-22. PubMed ID: 8072758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias.
    Brembilla-Perrot B; Houriez P; Beurrier D; Claudon O; Terrier de la Chaise A; Louis P
    Int J Cardiol; 2001 Aug; 80(1):7-15. PubMed ID: 11532541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tachycardia due to atrial flutter with rapid 1:1 conduction following treatment of atrial fibrillation with flecainide.
    Taylor R; Gandhi MM; Lloyd G
    BMJ; 2010 Mar; 340():b4684. PubMed ID: 20219811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atrial flutter with 1/1 nodo-ventricular conduction with amiodarone. From physiopathology to diagnosis].
    Aouate P; Elbaz N; Klug D; Lacotte J; Raguin D; Frank R; Lelouche D; Dubois-Randé JL; Tonet J; Fontaine G
    Arch Mal Coeur Vaiss; 2002 Dec; 95(12):1181-7. PubMed ID: 12611038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
    Jastrzebski M
    Kardiol Pol; 2008 Nov; 66(11):1221-4; discussion 1225. PubMed ID: 19105102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and electrophysiological characteristics of patients having atrial flutter with 1:1 atrioventricular conduction.
    Kawabata M; Hirao K; Higuchi K; Sasaki T; Furukawa T; Okada H; Hachiya H; Isobe M
    Europace; 2008 Mar; 10(3):284-8. PubMed ID: 18258806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proarrhythmic effects of class Ic drugs.
    Moroe K; Annoura M; Matsuo K; Yamanouchi Y; Kumagai K; Arakawa K
    Clin Ther; 1993; 15(3):559-66. PubMed ID: 8364947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arrhythmogenic risk of antiarrhythmic drugs: study with class Ic drugs during myocardial ischemia].
    Faucon G; Aupetit JF; Gerentes-Chassagne I; Loufoua-Moundanga J; Larbre JP; Timour Q
    Bull Acad Natl Med; 1991 Feb; 175(2):217-24; discussion 224-5. PubMed ID: 1907520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is newer better? Propafenone versus quinidine for conversion of atrial fibrillation.
    Daubert JP
    Cardiol J; 2009; 16(6):491-2. PubMed ID: 19950083
    [No Abstract]   [Full Text] [Related]  

  • 17. Atrial flutter with 1:1 atrioventricular conduction caused by propafenone.
    el-Harari MB; Adams PC
    Pacing Clin Electrophysiol; 1998 Oct; 21(10):1999-2001. PubMed ID: 9793099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive value of induction of atrial flutter or fibrillation in paroxysmal junctional tachycardia].
    Brembilla-Perrot B; Houriez P; Beurrier D; Preiss JP; Terrier de la Chaise A; Louis P; Claudon O
    Arch Mal Coeur Vaiss; 2000 Jan; 93(1):57-61. PubMed ID: 11227719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atrial electrophysiological study of unexplained ischemic cerebrovascular disorders].
    Reeb T; de Chillou C; Sadoul N; Lacour JC; Ducrocq X; Debouverie M; Weber M; Aliot E
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1855-61. PubMed ID: 8729366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.